MediXall Group, Inc. — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7fca7973-5b0c-4417-9493-972e97dd89d0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-4.6M | 2023-01-01 – 2023-12-31 | evidence 0001079973-25-000141 |
| FY 2022 | $-6.8M | 2022-01-01 – 2022-12-31 | evidence 0001079973-23-001099 |
| FY 2021 | $-6.2M | 2021-01-01 – 2021-12-31 | evidence 0001079973-22-000448 |
| FY 2020 | $-5.9M | 2020-01-01 – 2020-12-31 | evidence 0001553350-21-000523 |
| FY 2019 | $-3.4M | 2019-01-01 – 2019-12-31 | evidence 0001553350-20-000442 |
| FY 2018 | $-3.0M | 2018-01-01 – 2018-12-31 | evidence 0001553350-19-000563 |
| FY 2017 | $-1.6M | 2017-01-01 – 2017-12-31 | evidence 0001553350-19-000563 |
| FY 2016 | $-657.2k | 2016-01-01 – 2016-12-31 | evidence 0001553350-17-000330 |
| FY 2015 | $-348.6k | 2015-01-01 – 2015-12-31 | evidence 0001553350-16-001947 |
| FY 2014 | $-684.1k | 2014-01-01 – 2014-12-31 | evidence 0001553350-15-000498 |
| FY 2013 | $-988.2k | 2013-01-01 – 2013-12-31 | evidence 0001553350-15-000404 |
| FY 2012 | $-151.9k | 2012-01-01 – 2012-12-31 | evidence 0001553350-14-001513 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).